 |
 |
 |
 |
 |
|
|
|
|
|
 |
||
 |
||
 Editorial Director Christie M. Ballantyne, MD Editors Louis J. Aronne, MD, FACP Philip J. Barter, MD, PhD Thomas P. Bersot, MD, PhD H. Bryan Brewer, Jr, MD Eliot A. Brinton, MD John R. Crouse III, MD Margo A. Denke, MD Jean-Pierre Després, PhD, FAHA Henry Ginsberg, MD Antonio M. Gotto, Jr, MD, DPhil Steven M. Haffner, MD Peter H. Jones, MD Peter Libby, MD Michael Miller, MD Vijay Nambi, MD Daniel J. Rader, MD Paul Ridker, MD Salim S. Virani, MD Contributors Harold Bays, MD Kathy Berra, MSN, ANP, FAAN Kimberly K. Birtcher, MS, PharmD, BCPS, CDE, CLS Vera Bittner, MD, MSPH B. Greg Brown, MD Christopher P. Cannon, MD Beth Cocanougher-Short, BSN, MS David E. Cohen, MD, PhD Rory Collins, MB BS Tim Church, MD, MPH, PhD Michael H. Davidson, MD Anthony N. Fabricatore, PhD Gregg C. Fonarow, MD Scott M. Grundy, MD William S. Harris, PhD Willa A. Hsueh, MD Terry A. Jacobson, MD James M. McKenney, PharmD Richard W. Nesto, MD Shailesh B. Patel, BM, ChB, FRCP Duke Rohe LaDale K. St.Clair, MD Neil J. Stone, MD Allen J. Taylor, MD, FACC, FAHA Peter P. Toth, MD, PhD Madhuri M. Vasudevan, MD, MPH Sanjeev A. Vasudevan, MD Thomas A. Wadden, PhD Peter W. F. Wilson, MD Stephen C. Woods, PhD Also visit
|
 New in Clinical Cases A Case of a Patient with Diabetic Dyslipidemia This clinical case describes the management of a 55-year-old man with a 10-year history of type 2 diabetes mellitus and hypertension and a 2-year history of dyslipidemia who is evaluated for possible complications from his long-standing medical conditions.This CME activity has been approved for AMA PRA credit. |
Cardiometabolic Risk:
|
 |
|
